Amphix Bio: Funding, Investors & Team (Sep 2026)
Amphix Bio provides materials science, stem cell biology, biomolecular design, engineering, medical physics, and informatics. This has created translational opportunities for the development of novel therapies whose results in preclinical and clinical trials are promising.
Amphix Bio has raised $13.5M across 2 funding rounds on record, the most recent a Seed of $12.5M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Amphix Bio Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Amphix Bio Funding Rounds
Amphix Bio raised $1.0M in an undisclosed round announced in Oct 2024.
1.2 years later, a Seed of $12.5M was announced in Dec 2025.
Amphix Bio Founders and Leadership Team
Contact details for the Amphix Bio team: 1 of 2 have an email address on file.
Start 14-day free trial →Amphix Bio Funding Compared to Other Biotechnology Startups
Amphix Bio's latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Amphix Bio in Biotechnology and Chicago
Companies Similar to Amphix Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Amphix Bio Funding FAQs
What does Amphix Bio do?
Amphix Bio provides materials science, stem cell biology, biomolecular design, engineering, medical physics, and informatics. This has created translational opportunities for the development of novel therapies whose results in preclinical and clinical trials are promising.
How much funding has Amphix Bio raised?
Amphix Bio has raised $13.5M across 2 rounds on record. The most recent is a Seed of $12.5M announced in Dec 2025.
When did Amphix Bio last raise funding?
Amphix Bio's most recent funding round on record is a Seed of $12.5M, announced in Dec 2025.
Who founded Amphix Bio?
FundedIQ lists Nick Sather (Founder), Samuel Stupp (Founder) at Amphix Bio.
Where is Amphix Bio headquartered?
Amphix Bio is based in Chicago, Illinois, United States.
How many employees does Amphix Bio have?
Amphix Bio is in the 1-10 employee band.
How does Amphix Bio's funding compare to other Biotechnology startups?
Amphix Bio's latest round of $12.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Amphix Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Amphix Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.